SCHEMBL4464719

SCHEMBL4464719

CC(=O)NC(C(=O)N1CCOCC1)[C@@H](S)N=O

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 1/20 0.41
HTT P42858 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
GAA P10253 3/20 0.34
ACACB O00763 1/20 0.34
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464708 1.00 SMN1; SMN2 (0.41) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL4459973 0.84 CYP1A2 (0.39) CYP2C19ACACBKMT2AALDH1A1KDM4E
SCHEMBL4459962 0.84 CYP1A2 (0.39) CYP2C19ACACBKMT2AALDH1A1KDM4E
SCHEMBL13645754 0.80 SMN1; SMN2 (0.50) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL7719250 0.72 SMN1; SMN2 (0.50) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL7718204 0.71 SMN1; SMN2 (0.47) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL13645867 0.69 HTT (0.46) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL21655203 0.68 SMN1; SMN2 (0.50) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL14779934 0.67 SMN1; SMN2 (0.50) SMN1; SMN2PKMHTTCYP3A4CYP2C19
SCHEMBL13645758 0.67 HTT (0.44) SMN1; SMN2PKMHTTCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009151744-A1 S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES GALLEON PHARMACEUTICALS, INC. (US) 2009-12-17 WO claimed
WO-2009151744-A1 S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES GALLEON PHARMACEUTICALS, INC. (US) 2009-12-17 WO disclosed